Neuralink Competitor Science Corp Secures $104 Million in Funding Led by Khosla Ventures

In a significant development within the neuroscience and brain-computer interface sector, Science Corp, a prominent rival to Elon Musk's Neuralink, has successfully raised $104 million in a recent funding round. This financial boost underscores the burgeoning interest and competition in the realm of neural technologies.

Continue reading

FDA Officer Overseeing Musk's Neuralink Devices Terminated Amid Controversy

In a surprising turn of events, the U.S. Food and Drug Administration (FDA) has terminated an official who played a crucial role in overseeing Neuralink, the neurotechnology company founded by Elon Musk. The dismissal has raised eyebrows and concerns about the ongoing regulatory scrutiny that Neuralink faces as it aims to develop cutting-edge brain-computer interface devices.

Continue reading